PROFUSA, INC. Payments for Repurchase of Private Placement
PROFUSA, INC. (PFSA) reported Payments for Repurchase of Private Placement of $4.00 million for the 8-month period ending 2021-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2023-03-06
- 2021-12-31: Payments for Repurchase of Private Placement 8 month $4.00M.
| Period end | Payments for Repurchase of Private Placement 8 month |
|---|---|
| 2021-12-31 | $4.00M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |